Duo Oncology Inc.
Pharmaceutical company · Pittsburgh, Pennsylvania, United States
Duo Oncology Inc. is a pharmaceutical company headquartered in Pittsburgh, Pennsylvania, United States. Its earliest recorded incorporation is in 2020. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $849,937 in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $1.4 million sold in a notice filed in 2026.
Duo Oncology at a glance
What does Duo Oncology do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $849,937 in total (2023 to 2024). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $1.4 million sold (2026).
Frequently asked questions about Duo Oncology
Where is Duo Oncology headquartered?
Duo Oncology Inc. is headquartered in Pittsburgh, Pennsylvania, United States.
What does Duo Oncology do?
Duo Oncology Inc. is a pharmaceutical company.
When was Duo Oncology founded?
The earliest incorporation on record for Duo Oncology Inc. is in 2020, according to public company registers.
Similar companies
- Lipella Pharmaceuticals Inc.Pittsburgh, Pennsylvania, United States
- Thar Pharmaceuticals IncPittsburgh, Pennsylvania, United States
- Consegna Pharma Inc.Pittsburgh, Pennsylvania, United States
- Creegh Pharmaceuticals, Inc.Pittsburgh, Pennsylvania, United States
- NeuBase Therapeutics, Inc.Pittsburgh, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences